Dolutegravir for first-line antiretroviral therapy in low-income and middle-income countries: uncertainties and opportunities for implementation and research
Dorward, Jienchi, Lessells, Richard, Drain, Paul K, Naidoo, Kogieleum, de Oliveira, Tulio, Pillay, Yogan, Abdool Karim, Salim S, Garrett, NigelLanguage:
english
Journal:
The Lancet HIV
DOI:
10.1016/S2352-3018(18)30093-6
Date:
June, 2018
File:
PDF, 85 KB
english, 2018